Tian, Ying, Sheri E. Kelemen, and Michael V. Autieri. Inhibition of AIF-1 expression by constitutive siRNA expression reduces macrophage migration, proliferation, and signal transduction initiated by atherogenic stimuli.
MACROPHAGE ACTIVATION is an important component in the genesis and progression of inflammation. Macrophages are present at all stages in the development and progression of atherogenesis and are a major cellular component of the atherosclerotic plaque (16) . Macrophages within the plaque internalize oxidized LDL, which initiates signal transduction cascades and leads to activation of pathophysiological processes (15, 18, 24) . Activated macrophages also synthesize inflammatory and mitogenic cytokines, which have profound stimulatory effects on recruitment of inflammatory cells and activation of vascular endothelial cells and vascular smooth muscle cells (VSMC) (25) . Collectively, activated macrophages promote localized inflammation and plaque progression. This supports the importance of identification of molecules that regulate macrophage activation.
Allograft inflammatory factor-1 (AIF-1) is a 143-amino acid, cytoplasmic, evolutionarily conserved, calcium-binding protein. AIF-1 has signatures of a cytoplasmic signaling protein, including several motifs capable of interacting with PDZ domains, which are important in mediating interactions of large multiprotein complexes, and the QXXER motif, shown to mediate G␤␥ interactions (8, 18) . AIF-1 expression was originally reported to be restricted to cells of the monocyte/ macrophage lineage, as well as in microglial and dendritic cells (11) . Multiple reports from several investigators in varied experimental systems indicate that on the basis of its expression in infiltrating macrophages in inflamed tissue, AIF-1 expression can be considered a marker of activated macrophages. For example, Utans et al. (30) found that AIF-1 was expressed in activated macrophages in chronic (Lewis to F344 rats) cardiac transplants. In these studies, AIF-1 immunolocalized to macrophages infiltrating the myocardium at 7 days posttransplant and persisted in these cells to 75 days posttransplant. In renal biopsies, of several markers tested, including leukocyte surface antigens, cytokines, and activation markers, AIF-1-positive macrophages were the only marker able to distinguish subclinical from clinical rejection (14) . AIF-1 also localized to the macrophage infiltrate of pancreatic islets in prediabetic rats (7) . In skeletal muscle, AIF-1 expression was observed in macrophages within 48 h postdevascularization (20) . AIF-1 was found to be expressed in infiltrating macrophages in experimental autoimmune encephalomyelitis and neuritis, as well as in parenchymal cells in human brain infarcts and traumatic brain injury (26) . Robust AIF-1 expression is detected in the allograft response of the phylogenetically distant species carp and marine sponges (13, 19) . It is clear from this work that AIF-1 expression is a conserved response in inflammatory reactions.
Despite numerous studies that have correlated increases in AIF-1 expression with activated macrophages, a defined function for this protein in macrophage activation, and more specifically in the development of atherosclerosis, has yet to be elucidated. Previous work by our group (1) (2) (3) (4) 17) focused on cytokine-inducible AIF-1 expression in activated VSMC and showed that AIF-1 expression regulates VSMC migration and proliferation. Receptor-initiated signaling, migration, and proliferation are all hallmarks of macrophage activation. On the basis of these functional data, together with the numerous reports associating AIF-1 expression with activated macrophages, we hypothesized that AIF-1 activity is central for macrophage activation. In this study, we report that AIF-1 expression colocalizes with CD68 ϩ macrophages in human atherosclerotic arteries and that AIF-1 expression is inducible in macrophages by oxidized LDL. Furthermore, reduction of AIF-1 expression in macrophages by small interfering RNA (siRNA) abrogates their migration and proliferation and also attenuates atherogenic signal transduction cascades.
MATERIALS AND METHODS
Immunofluorescence. Human coronary arteries recovered from hearts removed from patients at the time of cardiac transplantation were fixed in 10% buffered formalin, embedded in paraffin, sectioned at 5 m, deparaffinized in Xylene, and rehydrated through graded alcohols as described previously (3) . Antigen unmasking was performed, and after blocking with 2% goat serum, sections were incubated with primary antibodies for 1 h at room temperature, followed by a 30-min incubation with secondary antibody conjugated to Alexa Fluor 568 (red) and Alexa Fluor 488 (green) (Molecular Probes). CD68 (macrophage marker; Neo Markers) were used at a concentration of 1.0 g/ml, and AIF-1 antibody was used at 0.5 g/ml.
siRNA expression plasmids. siRNA constructs used were synthesized by GenScript (Scotch Plains, NJ). Three prospective 19-bp regions of murine AIF-1 mRNA were targeted (5Ј to 3Ј): construct 1, AGAGAGGCTGGATGAGATC; construct 2, ACAAGCAATTC-CTAGACGA; and construct 3, TAGCAGTGATGAGGATCTG. They were chemically synthesized as part of a small, double-stranded 70-bp DNA insert containing the target sequence in the sense orientation, followed by a short loop region, the target in the antisense orientation, and six thymidines added to the 3Ј end, which serves as a polymerase III transcription termination site. This insert was flanked by BamHI and HindIII restriction sites and cloned into the siRNA expression vector pRNA-U6.1/shuttle (pShuttle), containing a RNA polymerase III promoter, which initiates the transcription of a short hairpin RNA rapidly processed by cellular machinery into 19-to 22-nt double-stranded RNA (siRNA). The pShuttle plasmid contains the selectable marker Neomycin to facilitate selection of stably transfected cells.
Cell culture and stable transfections. RAW264.7 cells, a commonly used mouse macrophage cell line, were obtained from the American Type Culture Collection. RAW264.7 were utilized because they constitutively express low levels of AIF-1 mRNA (29) and are adherent, facilitating positive selection of stable transfectants. RAW264.7 cells were cultured in DMEM with 10% FCS, 100 IU/ml penicillin, and 50 mg/ml streptomycin. Vector alone (pRNA-U6.1/ shuttle) was used as a negative control. Lipid-mediated transfection with pRNA-U6.1/shuttle plasmid alone or with pRNA-U6.1/shuttle AIF-1/siRNA was performed as described previously (4) . After antibiotic selection (400 g/ml G418; Fisher Biotechnology), transfectants were pooled to avoid the effects of clonal selection and were expanded in 125 g/ml G418. For rescue, cells stably transfected with AIF-1 siRNA were incubated with AIF-1 adenovirus (AdAIF; 50 multiplicities of infection) for 2 h. Primary human monocytes were obtained by venipuncture from normal, healthy individuals, separated from red blood cells by Ficoll-Hypaque centrifugation, and separated from lymphocytes and granulocytes by adherence to plastic for 2 h at 37°C. Adherent cells were cultured and stimulated as described for RAW264.7 cells.
Proliferation assay. Equal numbers of stable transfectants were seeded onto 12-well plates at a density of 7,500 cells/ml as described previously (4, 9) . Medium was changed on the fourth day, and after 4 and 7 days, cells were counted using a standard hemocytometer.
Migration assay. Standard Boyden chamber migration assays were performed as described previously (2) . Transwell Boyden chamber plates (6.5-mm diameter; Costar) with a 5-m polycarbonate membrane pore size were seeded with stably transfected or adenovirally rescued cells (10 6 cells per membrane) in medium containing 0.5% FCS as described previously (2) . Five nanograms of monocyte chemoattractant protein-1 (MCP-1; Sigma) were placed in the lower chamber, and cells were incubated for 3 h at 37°C, at which time cells were fixed and stained using Dif-Quick cell stain (American Hospital Supply). The upper layer was scraped free of cells. Cells that had migrated to the lower surface of the membrane were quantitated by counting four high-power fields per membrane. Experiments were performed in triplicate from three independently transfected groups of macrophages.
Oxidized LDL preparation. Human LDL was purchased from Sigma. For oxidation, LDL (1 mg/ml) was oxidized in PBS containing 20 M copper sulfate at 37°C for 24 h as described previously (5, 15) . Oxidation was arrested by addition of 1 mM EDTA (pH 8.5) and cooling. Protein concentration was determined using the Bradford assay method and applied within 1-3 days of preparation. For induction of AIF-1 expression, 20 g/ml was used; for induction of signaling cascades, 20 g/ml was used.
Western blotting. For preparation of cell extracts, primary human or RAW264.7 cells were washed with PBS and lysed by adding 2ϫ SDS sample buffer [125 mM Tris ⅐ HCl (pH 6.8 at 25°C), 4% (wt/vol) SDS, 1.6% (vol/vol) ␤-mercaptoethanol, 20% glycerol, and 0.02% (wt/vol) bromphenol blue] as described previously (21) . Extract proteins were separated using SDS-PAGE, transferred onto a nitrocellulose membrane, and blocked as described previously (9) . AIF-1 rabbit polyclonal antibody (1:3,000 dilution) as described previously (14), a 1:750 dilution of Multiplex Western Cocktail I (containing antiphospho-p90, Akt, p44/42, and S6), and anti-phospho-p38 (Cell Signaling Technology) as well as a 1:2,000 dilution of secondary antibody were used. Monoclonal active caspase-3 antibody (1:2,500 dilution) was obtained from BD Pharmingen. Equal loading of protein extracts on gels was verified by Ponceau S staining of the membrane and blotting with total p38, p90, Akt, p44/42, and S6 protein, as well as with the housekeeping protein anti-GAPDH (1:5,000 dilution; Biogenesis), and reactive proteins were visualized using enhanced chemiluminescence. To induce AIF-1 expression, we incubated human monocytes or RAW264.7 cells with oxidized LDL (20 g/ml) for the indicated times. For detection of activation of intracellular signaling proteins, cells were rinsed in PBS, starved in 0.5% DMEM for 48 h, and stimulated with 20% T-lymphocyte conditioned medium or oxidized LDL (20 g/ml) for the indicated times. Staurosporine was used at 5 M for 24 h as a positive control for induction of apoptosis (33) .
Statistical analysis. Experiments were repeated three times. Results from proliferation and migration are presented as means Ϯ SD and were compared using one-way ANOVA. Results form cell signaling transduction are presented as means Ϯ SE and were compared using two-way ANOVA and Bonferroni posttests. A value of P Յ 0.05 was considered significant. (3) . Although AIF-1 expression has been immunolocalized in human coronary arteries with transplant vasculopathy, its localization in human atherosclerotic arteries has not been reported. Twocolor immunofluorescent staining determined that AIF-1 protein colocalizes with CD68-positive cells in the media of human coronary arteries with atherosclerosis, demonstrating that infiltrating macrophages express high levels of AIF-1 (Fig. 1, A-D) . Macrophages in the atherosclerotic plaque exist in a milieu of modified lipids and inflammatory cytokines that initiate signal transduction cascades leading to cell activation (19) . Induction of AIF-1 expression by inflammatory cytokines in macrophages has been described previously (29, 31) , but induction by modified lipids has not. Because oxidized LDL is present in human atherosclerotic lesions, we investigated whether oxidized LDL is capable of inducing AIF-1 expression in macrophages. Primary monocytes/macrophages were isolated from healthy human donors and, along with RAW264.7 macrophages, a commonly used macrophage cell line, were treated with native and oxidized LDL. AIF-1 induction over time was determined using Western blotting. Figure 1E shows that oxidized LDL is a potent inducer of AIF-1 expression in both primary human monocytes/macrophages and RAW264.7 cells, with an eightfold increase in protein expression after 72 h. In contrast, unmodified LDL did not significantly induce AIF-1 expression in these cells.
RESULTS

AIF-1 is not detectable in normal arteries
Many descriptive studies have suggested that AIF-1 was important for macrophage activation. Because AIF-1 expression was similar in the RAW264.7 macrophage line and in primary human monocytes/macrophages, the RAW264.7 cells were used to characterize the functional significance of AIF-1 expression. RAW264.7 macrophages were used because they constitutively express low levels of AIF-1 mRNA, they have previously been utilized to study oxidized LDL metabolism, and induction of AIF-1 protein expression in these cells is comparable to primary human monocytes/macrophages (10, 29, 32) . Furthermore, because they are a cell line, they are more amenable for generation of homogeneous populations of stable transductants for better control of functional studies. Induction of AIF-1 expression is at the transcriptional level (4, 29, 30) , which makes it a target amenable for RNA knockdown. We tested the hypothesis that AIF-1 expression is important for macrophage activation by inhibiting AIF-1 expression in these cells using stable, vector-based siRNA expression and by analyzing macrophage functions such as proliferation, migration, and signal transduction cascades. Several siRNA constructs based on different regions of murine AIF-1 cDNA were cloned into the pShuttle vector. Macrophages were then transfected, stable transfectants were isolated by antibiotic selection, and populations of resistant cells were pooled to avoid the effects of clonal selection. Extracts were made from these cells, and AIF-1 expression was determined using Western blotting. Figure 2A shows that of the three siRNA constructs used, construct 1 reduced AIF-1 protein by an average of 79%, whereas other sequences did not. Proliferation is a hallmark of macrophage activation. To determine whether AIF-1 expression was required for macrophage proliferation, equal numbers of siRNA stable transfectants were seeded into replicate 12-well plates. Medium was replaced on the fourth day, and after 1, 4, and 7 days, the cells were counted. The results of three independent experiments demonstrate that macrophages in which AIF-1 is inhibited grow ϳ52% more slowly than do control vector-only cells (255 ϫ 10 3 Ϯ 20 and 583 ϫ 10 3 Ϯ 34 for siRNA construct 1 and control cells, respectively; P Ͻ 0.01). Untransfected control cells or other siRNA sequences that do not knock down AIF-1 expression have no inhibitory effect (Fig. 2B) . Consequently, cells transfected with siRNA construct 1 were used for subsequent experiments. To specify that growth inhibition was due to abrogation of AIF-1 expression, we infected siRNA construct 1 cells with AdAIF-1 to rescue AIF-1 expression. These experiments show that restoration of AIF-1 expression rescued the ability of these cells to proliferate by 170% (431 ϫ 10 3 Ϯ 67 and 1,160 ϫ 10 3 Ϯ 73 for siRNA and siRNA infected with AdAIF-1, respectively; P Ͻ 0.001) (Fig. 3) . Moreover, cells infected with AdAIF-1 grew 37% more rapidly than did control cells (845 ϫ 10 3 Ϯ 91 for control and 1,160 ϫ 10 3 Ϯ 73 for rescued cells, respectively; P Ͻ 0.005). siRNA cells infected with green fluorescent protein adenovirus (AdGFP) showed no change in growth capacity (data not shown).
It was important to establish that the reduction in cell numbers observed for siRNA macrophages was due to lower proliferation, not to deleterious effects of AIF-1 abrogation.
Extracts from pShuttle, siRNA, and siRNA AdAIF-1-rescued cells were subjected to Western blot analysis with anti-active caspase-3 antibody, which recognizes only activated caspase-3, a sensitive marker of apoptosis. A positive control was the addition for 24 h of 5 M staurosporine, a potent inducer of apoptosis in monocytes (33) . Figure 4 indicates that siRNA stable cells do not express active caspase-3, strongly suggesting that AIF-1 siRNA expression reduces macrophage proliferation rather than inducing apoptosis. Together, these data indicate that AIF-1 expression is tightly associated with cellular proliferation.
Macrophage infiltration into the atherosclerotic plaque is key for development of the atherosclerotic lesion (1-3). To determine whether AIF-1 plays a role in macrophage migration, we seeded control cells, siRNA stable transfectants, and siRNA macrophages that had been rescued with AdAIF-1 into Boyden chambers and induced migration by adding MCP-1, a strong macrophage chemoattractant. Differences in chemotaxis was quantitated by counting migrated cells. Figure 5 shows that macrophage migration is inhibited by 60% in siRNA-transfected cells (mean: 87.6 ϫ 10 3 Ϯ 9.6 vs. 35.1 ϫ 10 3 Ϯ 3.3 cells per high-power field for pShuttle control and siRNA, respectively; P Ͻ 0.01). Migration was restored by AdAIF-1 infection of siRNA-transduced cells (274.8 ϫ 10 3 Ϯ 21.7 vs. 35.15 ϫ 10 3 Ϯ 3.3 cells per high-power field for rescued and siRNA, respectively; P Ͻ 0.001). AdAIF-1-infected siRNA cells also migrated significantly more rapidly than did control Fig. 2 . Small interfering RNA (siRNA) knockdown of AIF-1 protein in macrophages. Three different siRNA sequences were generated to various parts of the AIF-1 cDNA and cloned into the pShuttle expression vector. A: stable transfectants were stimulated with 10 ng/ml IFN-␥ for 24 h to induce AIF-1 expression, and extracts were blotted with AIF-1 antibody. Protein expression was quantitated by densitometry. Blot (top) and graph (bottom) are representative of 3 experiments. B: inhibition of AIF-1 expression inhibits macrophage proliferation. Equal numbers of pooled, stable transfectants were seeded onto 12-well plates and grown in growth medium. After 1, 4, and 7 days, cells were counted in triplicate. Data are means from 3 independent transfections with similar results. The difference between siRNA #1 and control cells and other siRNA sequences is significant at 4 and 7 days (*P Ͻ 0.05).
cells (274.8 ϫ 10
3 Ϯ 21.7 vs. 87.6 ϫ 10 3 Ϯ 9.6 cells per high-power field; P Ͻ 0.01). siRNA cells infected with AdGFP showed no change in migration (data not shown). This experiment indicates that AIF-1 expression is a necessary component of macrophage chemotaxis.
Both oxidized LDL and inflammatory cytokines are effective inducers of signal transduction cascades in macrophages (12, 23) . AIF-1 contains motifs consistent with a scaffold protein, and we hypothesized that diminution of AIF-1 expression would disrupt oxidized LDL and inflammation-initiated signal transduction pathways. For these experiments, stable transfectants were incubated in serum-reduced medium for 48 h and then stimulated with 20 g/ml oxidized LDL, and phosphorylation of several cytoplasmic kinases was quantitated by Western blotting. Figure 6 shows that activation of Akt and the MAPK family kinases p44/42 and p38 were significantly reduced by reduction of AIF-1 expression. Both Akt and p44/42 phosphorylation were reduced 15 min poststimulation (P Ͻ 0.05). Interestingly, whereas reduction of AIF-1 did not appear to reduce oxidized LDL-induced phosphorylation of p38, it did significantly reduce basal levels of p38 phosphorylation. Phosphorylation of two other kinases investigated, p90RSK and S6 kinase, were increased by oxidized LDL, but reduction of AIF-1 had no effect on their activation. A similar experiment was performed using 20% T-lymphocyte-conditioned medium as a potent proinflammatory stimulus. Figure 7 demonstrates that reduction of AIF-1 results in significant inhibition of p38 activation at 5 and 15 min poststimulation (P Ͻ 0.05). In contrast to oxidized LDL, no significant inhibition of p44/42 MAPK was noted, but activation of p90RSK was inhibited 5 and 15 min poststimulation (P Ͻ 0.057). No significant inhibition of S6 kinase stimulation by T-lymphocyte-conditioned medium was observed. No significant difference in kinase activation was noted between pShuttle vector-and mock-transfected cells (data not shown). Together, these data indicate a close association between AIF-1 expression and activation of signal transduction cascades mediated by atherogenic stimuli.
DISCUSSION
Activated immune cells produce inflammatory cytokines and are considered the protagonists in the activation of vascular cells in the atherosclerotic lesion. Consequently, characterization of molecules involved in macrophage activation can increase understanding of the progression of atherosclerosis.
AIF-1 expression in human arteries with transplant vasculopathy and in cytokine-stimulated macrophages has been reported (3, 29 -31) . Induction of AIF-1 expression is at the transcriptional level (4, 29, 30) . AIF-1 mRNA has been identified as one of a number of transcripts representative of the atherosclerotic burden in human aorta (27) . Nevertheless, no link has been made between AIF-1 expression and function in the development of atherosclerosis. In our analysis, AIF-1 protein localization in macrophages in atherosclerotic human arteries suggested the additional possibility of induction by oxidized lipids. This study is the first to demonstrate that oxidized LDL, but not native LDL, is a strong inducer of AIF-1 protein expression in monocytes/macrophages. equal numbers of pooled, stable transfectants and siRNA #1 infected with 50 MOI AdAIF-1 were seeded onto 12-well plates and grown in growth medium. After 1, 4, and 7 days, cells were counted in triplicate. Data are means from 3 independent transfections with similar results. The differences between siRNA #1 and control cells (*P Ͻ 0.001) and between rescued and siRNA #1 (*P Ͻ 0.001) are statistically significant at 4 and 7 days. The difference between rescued and control cells also is significant at 4 and 7 days (*P Ͻ 0.005, for each).
The functional consequences of AIF-1 expression in macrophages has not been determined; therefore, we used siRNA technology to reduce AIF-1 expression in these cells. Vectorbased delivery, rather than transfection of oligonucleotides, was used because it has been found to be more effective than synthetic siRNA for inhibition of gene expression, likely as a result of increased stability (6) . Use of an antibiotic-selectable vector also allowed the establishment of stable cell lines expressing consistent and reproducible amounts of siRNA to reduce experimental variability. Replication of macrophages in the atherosclerotic plaque has been reported by some investigators (24) but remains controversial in humans. However, monocyte/macrophage replication is an important component of inflammation. An AIF-1 siRNA sequence that effectively knocked down protein expression significantly reduced macrophage expression, whereas other siRNA sequences that did not reduce AIF-1 expression did not reduce proliferation. Furthermore, when AIF-1 expression in the siRNA macrophages was rescued with AdAIF-1, the proliferative capacity was not only restored but enhanced. It was possible that abrogation of AIF-1 expression would be deleterious to the cell and initiate apoptosis, which would be reflected in lower cell numbers in the proliferation assay. This also was a concern in light of suppression of Akt activation in the siRNA-expressing cells. This is not the case, because siRNA-expressing cells do not express active caspase-3, a sensitive and specific marker of cellular apoptosis. This finding confirms a tight association between AIF-1 expression and cell proliferation and is consistent with our previous findings in VSMC in which overexpression enhanced proliferation (4, 9) . Other investigators found that overexpression of AIF-1 in RAW264.7 macrophages re- sulted in increased IL-10 and IL-12 production in response to lipopolysaccharide stimulation (32) . In this study, we were unable to detect any decrease in these cytokines with siRNA treatment. In addition, we determined that abrogation of AIF-1 expression significantly reduced migration of macrophages. This inhibition also could be rescued by infection with AdAIF-1 and is consistent with our previous report (2) indicating that AIF-1 plays a role in VSMC migration.
Multiple studies have shown that receptor-mediated oxidized LDL uptake triggers signal transduction cascades, cytokine synthesis, and macrophage activation (15, 18, 23) . AIF-1 is a cytoplasmic calcium-binding protein. Binding of calcium to regulatory EF-hand proteins induces a conformational change that often mediates signaling cascades. AIF-1 also includes several motifs capable of interacting with PDZ interaction domains, which are important in regulating interactions of multiprotein complexes (8, 17) . Together, these characteristics suggested that reduction of AIF-1 protein expression might interrupt signaling cascades important in macrophage activation.
Reduction of AIF-1 expression significantly inhibited oxidized LDL activation of Akt and p44/42 MAPK, which is noteworthy in that activation of both of these kinases has been shown to be essential in oxidized LDL-mediated macrophage activation (17, 27) . Absence of AIF-1 inhibited basal but not oxidized LDL-mediated activation of p38 kinase, suggesting that AIF-1 mediates activation of a kinase proximal to basal p38 phosphorylation but not those directly involved in oxidized LDL-initiated activation. This finding is relevant in that p38 activation is a necessary component of macrophage proliferation and migration (22, 27) . Consequently, inhibition of basal levels of p38 phosphorylation in AIF-1 siRNA cells may provide a mechanism for their impaired proliferative capacity. Other kinases activated by oxidized LDL were not inhibited by reduction of AIF-1 expression, suggesting a specificity of pathways mediated by AIF-1. T-lymphocyte-conditioned medium contains multiple inflammatory and growth factors secreted by activated lymphocytes and closely mirrors the in vivo situation in which multiple signaling cascades are active. Reduction of AIF-1 results in a significant inhibition of p38 activation at 5 and 15 min poststimulation. Basal levels of p38 also are inhibited, but not significantly. In contrast to oxidized LDL, no significant inhibition of p44/42 MAPK or Akt was noted, likely because of cross talk from the multiple stimuli present in T-cell-conditioned medium. The differences noted between conditioned medium and oxidized LDL may reflect differences between the signaling pathways utilized by each stimuli or the specificity of the pathway that AIF-1 mediates. Together, these data indicate a close association between AIF-1 expression and activation of signal transduction cascades mediated by atherogenic stimuli.
The most direct explanation for these inhibitory effects is that based on its protein structure, in which AIF-1 acts as a scaffold protein that anchors members of signaling cascades into reactive proximity. In the absence of AIF-1, cascades are interrupted, resulting in suppressed activation of kinases distal from AIF-1. In this sense, AIF-1 acts as an inflammationresponsive signal regulator in macrophages. We have not been able to show a direct interaction between AIF-1 and p38, Akt, or p44/42, suggesting that the effects of AIF-1 on these kinases are proximal to their activation. Alternatively, one study (32) reported that overexpression of AIF-1 in macrophages leads to increased LPS-mediated IL-10 and IL-12 production. Although an alteration in expression of either of these cytokines with AIF-1 siRNA was not detected, the potential exists that inhibition of AIF-1 may abrogate autocrine production of cytokines, resulting in reduced basal signal transduction in siRNAtreated cells.
Although increased AIF-1 expression in activated macrophages has been described, there are several novel points to this study. First, AIF-1 is detected in macrophages in human atherosclerotic arteries, and its expression can be induced by stimulation with oxidized LDL but not native LDL. Second, knockdown of AIF-1 protein by stable transfection of siRNA reduces the important macrophage activities of proliferation and migration. These activities could be restored by rescue of AIF-1 expression. Apoptosis is not induced by AIF-1 siRNA. Third, the potential mechanism of these effects is a reduction in signal transduction, regardless of whether the stimuli comprise inflammatory cytokines or oxidized LDL. It is clear from multiple descriptive reports that AIF-1 expression is a fundamental part of the inflammatory process. The data presented in this study extend these reports and show that AIF-1 expression is crucial for macrophage activation, particularly in response to atherogenic stimuli.
